{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T19:06:15Z","timestamp":1763233575501},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s12265-010-9182-x","type":"journal-article","created":{"date-parts":[[2010,4,30]],"date-time":"2010-04-30T15:42:37Z","timestamp":1272642157000},"page":"304-313","source":"Crossref","is-referenced-by-count":27,"title":["Nifedipine Inhibits Cardiac Hypertrophy and Left Ventricular Dysfunction in Response to Pressure Overload"],"prefix":"10.1007","volume":"3","author":[{"given":"Tetsuro","family":"Ago","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiyong","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Sadoshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,1]]},"reference":[{"issue":"1","key":"9182_CR1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.RES.0000197782.21444.8f","volume":"98","author":"J Backs","year":"2006","unstructured":"Backs, J., & Olson, E. N. (2006). Control of cardiac growth by histone acetylation\/deacetylation. Circulation Research, 98(1), 15\u201324.","journal-title":"Circulation Research"},{"key":"9182_CR2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/eurheartj\/5.suppl_F.53","volume":"5","author":"BE Strauer","year":"1984","unstructured":"Strauer, B. E., Atef Mahmoud, M., Bayer, F., Bohn, I., Motz, U., & Suppl F. (1984). Reversal of left ventricular hypertrophy and improvement of cardiac function in man by nifedipine. European Heart Journal, 5, 53\u201360.","journal-title":"European Heart Journal"},{"issue":"1","key":"9182_CR3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1291\/hypres.25.117","volume":"25","author":"Y Zou","year":"2002","unstructured":"Zou, Y., Yamazaki, T., Nakagawa, K., Yamada, H., Iriguchi, N., Toko, H., et al. (2002). Continuous blockade of L-type Ca2+ channels suppresses activation of calcineurin and development of cardiac hypertrophy in spontaneously hypertensive rats. Hypertension Research, 25(1), 117\u2013124.","journal-title":"Hypertension Research"},{"issue":"3","key":"9182_CR4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/01.hjh.0000160223.94220.29","volume":"23","author":"J Lubsen","year":"2005","unstructured":"Lubsen, J., Wagener, G., Kirwan, B. A., de Brouwer, S., & Poole-Wilson, P. A. (2005). Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: The ACTION trial. Journal of Hypertension, 23(3), 641\u2013648.","journal-title":"Journal of Hypertension"},{"issue":"19","key":"9182_CR5","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1093\/emboj\/cdg474","volume":"22","author":"Q Liang","year":"2003","unstructured":"Liang, Q., Bueno, O. F., Wilkins, B. J., Kuan, C. Y., Xia, Y., & Molkentin, J. D. (2003). c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling. EMBO Journal, 22(19), 5079\u20135089.","journal-title":"EMBO Journal"},{"issue":"30","key":"9182_CR6","doi-asserted-by":"crossref","first-page":"28586","DOI":"10.1074\/jbc.M103166200","volume":"276","author":"C Morisco","year":"2001","unstructured":"Morisco, C., Seta, K., Hardt, S. E., Lee, Y., Vatner, S. F., & Sadoshima, J. (2001). Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes. Journal of Biological Chemistry, 276(30), 28586\u201328597.","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"9182_CR7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI0214938","volume":"110","author":"J Sadoshima","year":"2002","unstructured":"Sadoshima, J., Montagne, O., Wang, Q., Yang, G., Warden, J., Liu, J., et al. (2002). The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy. Journal of Clinical Investigation, 110(2), 271\u2013279.","journal-title":"Journal of Clinical Investigation"},{"issue":"11","key":"9182_CR8","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1161\/CIRCRESAHA.108.180042","volume":"103","author":"Y Matsui","year":"2008","unstructured":"Matsui, Y., Nakano, N., Shao, D., Gao, S., Luo, W., Hong, C., et al. (2008). Lats2 is a negative regulator of myocyte size in the heart. Circulation Research, 103(11), 1309\u20131318.","journal-title":"Circulation Research"},{"issue":"2","key":"9182_CR9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2174\/092986708783330557","volume":"15","author":"S Yamagishi","year":"2008","unstructured":"Yamagishi, S., Nakamura, K., & Matsui, T. (2008). Role of oxidative stress in the development of vascular injury and its therapeutic intervention by nifedipine. Current Medicinal Chemistry, 15(2), 172\u2013177.","journal-title":"Current Medicinal Chemistry"},{"issue":"5","key":"9182_CR10","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1074\/jbc.M004888200","volume":"276","author":"JW Neal","year":"2001","unstructured":"Neal, J. W., & Clipstone, N. A. (2001). Glycogen synthase kinase-3 inhibits the DNA binding activity of NFATc. Journal of Biological Chemistry, 276(5), 3666\u20133673.","journal-title":"Journal of Biological Chemistry"},{"issue":"22","key":"9182_CR11","doi-asserted-by":"crossref","first-page":"9936","DOI":"10.1128\/MCB.25.22.9936-9948.2005","volume":"25","author":"YS Dai","year":"2005","unstructured":"Dai, Y. S., Xu, J., & Molkentin, J. D. (2005). The DnaJ-related factor Mrj interacts with nuclear factor of activated T cells c3 and mediates transcriptional repression through class II histone deacetylase recruitment. Molecular and Cellular Biology, 25(22), 9936\u20139948.","journal-title":"Molecular and Cellular Biology"},{"issue":"4","key":"9182_CR12","doi-asserted-by":"crossref","first-page":"H1043","DOI":"10.1152\/ajpheart.00990.2002","volume":"284","author":"C Morisco","year":"2003","unstructured":"Morisco, C., Sadoshima, J., Trimarco, B., Arora, R., Vatner, D. E., & Vatner, S. F. (2003). Is treating cardiac hypertrophy salutary or detrimental: The two faces of Janus. American Journal of Physiology. Heart and Circulatory Physiology, 284(4), H1043\u2013H1047.","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"1","key":"9182_CR13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/hc0102.101365","volume":"105","author":"G Esposito","year":"2002","unstructured":"Esposito, G., Rapacciuolo, A., Naga Prasad, S. V., Takaoka, H., Thomas, S. A., Koch, W. J., et al. (2002). Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation, 105(1), 85\u201392.","journal-title":"Circulation"},{"key":"9182_CR14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1152\/physiol.00033.2006","volume":"22","author":"A Diwan","year":"2007","unstructured":"Diwan, A., & Dorn, G. W., 2nd. (2007). Decompensation of cardiac hypertrophy: Cellular mechanisms and novel therapeutic targets. Physiology (Bethesda), 22, 56\u201364.","journal-title":"Physiology (Bethesda)"},{"issue":"1","key":"9182_CR15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/01.RES.0000109415.17511.18","volume":"94","author":"BJ Wilkins","year":"2004","unstructured":"Wilkins, B. J., Dai, Y. S., Bueno, O. F., Parsons, S. A., Xu, J., Plank, D. M., et al. (2004). Calcineurin\/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circulation Research, 94(1), 110\u2013118.","journal-title":"Circulation Research"},{"issue":"3","key":"9182_CR16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cardiores.2004.04.026","volume":"63","author":"T Zhang","year":"2004","unstructured":"Zhang, T., & Brown, J. H. (2004). Role of Ca2+\/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. Cardiovascular Research, 63(3), 476\u2013486.","journal-title":"Cardiovascular Research"},{"issue":"48","key":"9182_CR17","doi-asserted-by":"crossref","first-page":"35078","DOI":"10.1074\/jbc.M707083200","volume":"282","author":"T Zhang","year":"2007","unstructured":"Zhang, T., Kohlhaas, M., Backs, J., Mishra, S., Phillips, W., Dybkova, N., et al. (2007). CaMKIIdelta isoforms differentially affect calcium handling but similarly regulate HDAC\/MEF2 transcriptional responses. Journal of Biological Chemistry, 282(48), 35078\u201335087.","journal-title":"Journal of Biological Chemistry"},{"issue":"8","key":"9182_CR18","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/01.RES.0000069686.31472.C5","volume":"92","author":"T Zhang","year":"2003","unstructured":"Zhang, T., Maier, L. S., Dalton, N. D., Miyamoto, S., Ross, J., Jr., Bers, D. M., et al. (2003). The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circulation Research, 92(8), 912\u2013919.","journal-title":"Circulation Research"},{"issue":"19","key":"9182_CR19","doi-asserted-by":"crossref","first-page":"8374","DOI":"10.1128\/MCB.24.19.8374-8385.2004","volume":"24","author":"RB Vega","year":"2004","unstructured":"Vega, R. B., Harrison, B. C., Meadows, E., Roberts, C. R., Papst, P. J., Olson, E. N., et al. (2004). Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Molecular and Cellular Biology, 24(19), 8374\u20138385.","journal-title":"Molecular and Cellular Biology"},{"issue":"34","key":"9182_CR20","doi-asserted-by":"crossref","first-page":"12457","DOI":"10.1073\/pnas.0803153105","volume":"105","author":"JS Martini","year":"2008","unstructured":"Martini, J. S., Raake, P., Vinge, L. E., DeGeorge, B., Jr., Chuprun, J. K., Harris, D. M., et al. (2008). Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes. Proceedings of the National Academy of Sciences of the United States of America, 105(34), 12457\u201312462.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"9182_CR21","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nm1573","volume":"13","author":"R Berdeaux","year":"2007","unstructured":"Berdeaux, R., Goebel, N., Banaszynski, L., Takemori, H., Wandless, T., Shelton, G. D., et al. (2007). SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes. Nature Medicine, 13(5), 597\u2013603.","journal-title":"Nature Medicine"},{"issue":"23","key":"9182_CR22","doi-asserted-by":"crossref","first-page":"8120","DOI":"10.1073\/pnas.0503275102","volume":"102","author":"S Chang","year":"2005","unstructured":"Chang, S., Bezprozvannaya, S., Li, S., & Olson, E. N. (2005). An expression screen reveals modulators of class II histone deacetylase phosphorylation. Proceedings of the National Academy of Sciences of the United States of America, 102(23), 8120\u20138125.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"9182_CR23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1172\/JCI27824","volume":"116","author":"JD Molkentin","year":"2006","unstructured":"Molkentin, J. D. (2006). Dichotomy of Ca2+ in the heart: Contraction versus intracellular signaling. Journal of Clinical Investigation, 116(3), 623\u2013626.","journal-title":"Journal of Clinical Investigation"},{"issue":"6","key":"9182_CR24","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.cell.2008.04.041","volume":"133","author":"T Ago","year":"2008","unstructured":"Ago, T., Liu, T., Zhai, P., Chen, W., Li, H., Molkentin, J. D., et al. (2008). A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy. Cell, 133(6), 978\u2013993.","journal-title":"Cell"},{"issue":"3","key":"9182_CR25","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2008.02.048","volume":"133","author":"JR Erickson","year":"2008","unstructured":"Erickson, J. R., Joiner, M. L., Guan, X., Kutschke, W., Yang, J., Oddis, C. V., et al. (2008). A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell, 133(3), 462\u2013474.","journal-title":"Cell"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-010-9182-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12265-010-9182-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-010-9182-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T06:56:14Z","timestamp":1559458574000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12265-010-9182-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,1]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["9182"],"URL":"https:\/\/doi.org\/10.1007\/s12265-010-9182-x","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,1]]}}}